Abstract 1325: Preclinical assessment of BT5528 anti-tumor activity in cell-line-derived xenograft (CDX) models of head and neck squamous cell carcinoma (HNSCC).
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Cambridge Science Centre
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148772829
Cites:
Cited by:
Related to: